Inteligex is a cell therapy company focused on solving currently incurable conditions of the central nervous system.
Toronto, Ontario
Joined June 2019
- Tweets89
- Following65
- Followers86
- Likes79
Inteligex retweeted
Learn more about Give Back Health and their partnership with Inteligex to bring the first effective regenerative treatment for spinal cord injury to market.
youtube.com/watch?v=In_9A16_…
givebackhealth.org/inteligex…
Looking forward to working with Give Back Health Innovation Foundation to advance our therapeutic platform!
Some exciting news for Inteligex!!!
givebackhealth.org/inteligex…
Learn more about Inteligex here:
inteligexinc.com/
@InteligexCells
New publication from Inteligex team members Drs. Khazaei and Fehlings demonstrating that human spinal oligodendrogenic neural progenitor cells improve functional recovery in a cervical spinal cord injury model.
New publication: Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model @KBI_UHN @IMSToronto
academic.oup.com/stcltm/adva…
A great @AuthorityMgzine feature on our Founder & President, Dr. Michael Fehlings!
Health Tech: Dr Michael Fehlings of Inteligex On How Their Technology Can Make An Important Impact medium.com/authority-magazin…
Next week Inteligex's CSO Dr. Mamad Khazaei will be in Boston to speak at the iPSC Manufacturing Summit!
ipsc-manufacturing-summit.co…
Inteligex Founder & President Dr. Michael Fehlings will be a featured presenter at the first-ever SCI Investor Symposium this June in San Diego!!
@SciSymposium @praxis_sci
We’re pleased to announce the addition of EG 427 and @DrFehlings to the presenter lineup for the 1st Annual #SCIsymposium.
Learn more: bit.ly/3mzDtOX
#SCI #SpinalCordInjury
Our Founder @DrFehlings leading the 2022 Basic-Translational-Clinical Roundtable: Advancing Treatments to Drive Functional Restoration After Spinal Cord Injury: Developing a Pathway to Facilitate the Translational Pipeline at @SfN_Events !!
It was great to have an opportunity to speak at the @SfN_Events '2022 Basic-Translational-Clinical Roundtable: Advancing Treatments to Drive Functional Restoration After Spinal Cord Injury: Developing a Pathway to Facilitate the Translational Pipeline'! @KBI_UHN @UofTSpine #SCI
It is great to be over in Israel as part of the @UTESTto Innovation and Entrepreneurial Exchange Program! #innovation #celltherapy
Inteligex retweeted
Congrats @Inteligex founder & @UofT Prof, @DrFehlings. He recently received:
🔹 2022 Apple award for excellence in spinal cord injury (SCI) rehabilitation literature
🔹@Nature's #1 author in the world for articles relevant to #SCI in the last 20 years
lnkd.in/gaYEGBcE
Inteligex Founding Member and CSO Dr. Mamad Khazaei recently won the Best Oral Presentation Award at the International Neurotrauma Symposium in Berlin!
Congratulations to Dr. Mamad Khazaei on receiving the Best Oral Presentation Award at the @neurotrauma2022 meeting in Berlin!! @UofTSpine @KBI_UHN @inteligex
Inteligex retweeted
I was fortunate to have the opportunity to be President of the International Neurotrauma Society and to organize the meeting in Toronto in 2018. It is great to be meeting in person in Berlin at another great INTS meeting. More updates to follow! @UofTSpine @KBI_UHN
We are excited to be a part of this important @praxis_sci program that helps bring exciting new products to those living with spinal cord injuries. Stay tuned for more updates!
Please join us in welcoming our 2022 Praxis #SCIAccelerate cohort! Praxis is pleased to announce four companies that will spend the next few months working closely with Praxis' commercialization, consumer and research teams. praxisinstitute.org/praxis-s…
ALT Black and white background with text "Praxis SCI Accelerate 2022 Cohort" along with company logos of comphya, Game Changer Tech, Inteligex and Munevo.
Congratulations Dr. Ahuja!!
A huge congratulations to @SuganthSuppiah, @jetanbadhiwala, and Dr. Chris Ahuja for successfully completing your Royal College exams!
#Neurosurgery #Neurosurgeon #RoyalCollege
A great recent publication discussing cell-based therapies for spinal cord injury, including lessons learned from clinical trials. It is an exciting era and we are proud to be at the forefront of this work. authors.elsevier.com/c/1f3d5…
Exciting to see this @ELSneuroscience textbook, led by Inteligex Founder Dr. Michael Fehlings, published! This book will be the go-to resource on spinal cord injury and spine trauma for years to come! #spinalcordinjury #SCI #trauma
Excited to announce that our book "Neural Repair and Regeneration after Spinal Cord Injury and Spine Trauma" is now published!! Thanks to everyone who contributed to this book and the @ELSneuroscience team for supporting us!!
elsevier.com/books/neural-re…